Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +743.86%
#3 ADO Protocol ADO Protocol +102.08%
#4 Cortex Cortex +93.89%
#5 Ontology Gas Ontology Gas +72.09%
#6 Kinesis Silver Kinesis Silver +54.02%
#7 OpenEden OpenEden +26.70%
#8 Magma Finance Magma Finance +24.81%
#9 QuantixAI QuantixAI +23.11%
#10 EXOD EXOD +22.78%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Viking Therapeutics, Inc. Viking Therapeutics, Inc.

Viking Therapeutics, Inc.

VKTX
Classement en actions #4202
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.
Prix de l'action
$34.49
Capitalisation boursière
$4.02B
Changement (1 jour)
0.93%
Changement (1 an)
32.44%
Pays
US
Échange Viking Therapeutics, Inc. (VKTX)

Catégorie

Healthcare
Historique du prix de l'action pour Viking Therapeutics, Inc. (VKTX)
Prix de clôture le plus élevé : $33.94 le 2026-08-01

Prix de clôture le plus bas : $8.59 le 2015-04-01
Historique du prix de l'action de Viking Therapeutics, Inc. de 2015 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -9.08%
2025 -20.83%
2024 152.59%
2023 215.71%
2022 16.84%
2021 -21.08%
2020 -20.48%
2019 -10.51%
2018 130.53%
2017 246.93%
2016 -60.36%
2015 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.57 41.68%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.98%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.62 -12.98%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $146.13 490.91%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.47 6.25%
CH